|
Dec 8
|
Here’s Why Surgery Partners (SGRY) Declined in Q3
|
|
Dec 8
|
Does Insulet (PODD) Face Challenges from the New Weight Loss Drug?
|
|
Dec 7
|
Medtronic scraps plans to buy insulin patch-pump maker EOFlow
|
|
Dec 5
|
The Zacks Analyst Blog Highlights NVIDIA, Vertiv Holdings, Copart, Insulet and Constellation Energy
|
|
Dec 5
|
Zacks.com featured highlights Insulet, W.R. Berkley, Invitation Home and VICI Properties
|
|
Dec 4
|
GM upgraded, Lululemon downgraded: Wall Street's top analyst calls
|
|
Dec 4
|
Top 5 Momentum Picks for December After Rejuvenated November
|
|
Nov 30
|
Salesforce and Expedia Are Among November’s Top Performers—and These Are the Worst
|
|
Nov 30
|
Charles River (CRL) Gains on Price & Volume Growth Amid FX Woe
|
|
Nov 29
|
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
|
|
Nov 28
|
Insulet to Present at Upcoming Investor Conferences
|
|
Nov 27
|
3 Reasons Why Growth Investors Shouldn't Overlook Insulet (PODD)
|
|
Nov 26
|
12 Best Diabetes Stocks To Buy Now
|
|
Sep 12
|
Insulet (PODD) Expands Omnipod 5 Even As Macro Woes Linger
|
|
Sep 8
|
Zacks Investment Ideas feature highlights: Workday, Energy Transfer and Insulet
|
|
Sep 7
|
Insider Buys: 3 CEOs Scooping Up Shares
|
|
Sep 7
|
Why Insulet Stock Is Sinking Today
|
|
Sep 7
|
Is It Time to Buy the S&P 500's 3 Worst-Performing August Stocks?
|
|
Sep 6
|
Insulet (PODD): A Hidden Gem in the Market? An In-Depth Analysis of Its Valuation
|
|
Aug 10
|
Insulet (PODD): A Significantly Undervalued Gem in Medical Devices & Instruments Industry?
|